OpenExamsFREE PRACTICE — ANY EXAM

Arkansas Pharmacist — Requirements & Free Practice

US-AR · License preparation

484 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist License

Arkansas license to practice pharmacy.

Licensing authority: Arkansas State Board of Pharmacy · Application information

Licensure by examination
Background Check
State and federal criminal background checks are required (17 CAR § 160-401(4)).
Education
Approved pharmacy degree, or foreign graduate qualification with FPGEC certification (Ark. Code Ann. § 17-92-305(a); 17 CAR § 160-401(1)).
Internship
2,000 hours of acceptable practical experience or training under Board approved conditions (17 CAR §§ 160-303(c), 160-401(1)).
Jurisprudence Timing
A score of at least 70 percent on the Arkansas jurisprudence exam is required before the licensure application (17 CAR § 160-401(8)).
Minimum Age
Applicant must be at least 21 years old (Ark. Code Ann. § 17-92-305(a)).
Licensure by reciprocity
Arkansas Jurisprudence Examination
Application
Complete NABP licensure transfer and Arkansas reciprocity applications, criminal background check, continuing education evidence, photograph and identification (17 CAR § 160-501; Board application).
Board Meeting
Applicant meets with the Board and takes the Arkansas paper jurisprudence examination in Arkansas (Board reciprocity application).
Original License
Active original pharmacist license in another jurisdiction; generally held for at least six months; California original license must have been issued on or after January 1, 2004 (Board reciprocity application; 17 CAR § 160-501(c)).
Practice After Inactivity
Supervised practice or Board waiver may be required under 17 CAR § 160-203.
Reinstatement after license lapse
No examination is required for this applicant pathway.
Competence
Satisfy the Board of competence and qualification to compound and fill prescriptions (17 CAR § 160-105(g)(2)(B)).
Fees
Pay the reinstatement and current renewal fees (17 CAR § 160-105(g)(2)(B)).
Inactivity
Immediate unsupervised practice is available only when lapse is no more than two calendar years; longer inactivity invokes supervised practice and a return-to-practice plan (17 CAR § 160-203).

Official no-examination sources

Effective from 2026-09-22.

Biennial renewal of pharmacist license
No examination is required for this applicant pathway.
Continuing Education
Complete 30 hours of continuing education each biennium, including live contact and accredited hour requirements (17 CAR § 160-803).
Fee
Pay the pharmacist renewal fee (17 CAR § 160-105(g)(2)).

Official no-examination sources

Effective from 2026-09-22.

Licensure by examination through NAPLEX score transfer
Other Requirements
The examination route's education, internship, criminal background and Arkansas jurisprudence score conditions remain applicable (17 CAR §§ 160-401, 160-402).
Score Transfer
NAPLEX taken in another participating state must be properly transferred to Arkansas; licensure occurs within 12 months of receipt after other requirements are completed (17 CAR § 160-402).

Pharmacist Preceptor Certification

Board certification for a pharmacist training interns or externs.

Licensing authority: Arkansas State Board of Pharmacy

Preceptor certification renewal
No examination is required for this applicant pathway.
Application And Fee
Renew every two years by application and fee (17 CAR § 160-305(b)(9)).

Official no-examination sources

Effective from 2026-09-22.

Pharmacy Certificate Denoting Special Recognition

Recognition certificate for an eligible long-serving pharmacist.

Licensing authority: Arkansas State Board of Pharmacy

Special recognition certificate for long serving pharmacist
No examination is required for this applicant pathway.
Eligibility
Either graduated from a Board approved pharmacy college at least 50 years earlier or held an Arkansas pharmacist license for 49 continuous years without lapse in licensure fee payments (Ark. Code Ann. § 17-92-309(c)).

Official no-examination sources

Effective from 2026-09-22.

Temporary Pharmacist Certificate

Temporary reciprocity authority between Board meetings.

Licensing authority: Arkansas State Board of Pharmacy · Application information

Temporary reciprocity certificate between Board meetings
Arkansas Jurisprudence Examination
Board Contact
Board member must personally talk to applicant and confirm passing Arkansas jurisprudence examination (17 CAR § 160-501(b)).
Expiry
Certificate expires at the next Board meeting, subject to the rule's 180-day outer limit (Ark. Code Ann. § 17-92-308(c); 17 CAR § 160-501(a)).
Underlying Application
Reciprocity applicant must have approved NABP preliminary application, Arkansas application, fees, background checks, continuing education proof, birth certificate and photograph (17 CAR § 160-501(a)).

Arkansas Jurisprudence Examination

Provider
Arkansas State Board of Pharmacy
Format
Paper and pencil; true or false and multiple choice
Exam questions
76
Passing score
70
Practice scope

Inferred from the examination name; the authority has not published an examination outline.

  • Arkansas Pharmacy Practice Act
  • Part 160. Arkansas State Board of Pharmacy Rules
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources